A new systematic review and meta-analysis is helping shine a spotlight on one of the least understood groups: high-grade endometrioid endometrial cancers with no specific molecular profile (NSMP). The findings suggest that this subtype represents nearly one-third of high-grade endometrial cancers and may play an important role in the future of personalized cancer care.




